Schechter Investment Advisors LLC Sells 66 Shares of Lam Research Co. (NASDAQ:LRCX)

Schechter Investment Advisors LLC trimmed its holdings in shares of Lam Research Co. (NASDAQ:LRCX) by 3.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,613 shares of the semiconductor company’s stock after selling 66 shares during the period. Schechter Investment Advisors LLC’s holdings in Lam Research were worth $1,263,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Assenagon Asset Management S.A. lifted its holdings in shares of Lam Research by 20.3% during the 4th quarter. Assenagon Asset Management S.A. now owns 103,003 shares of the semiconductor company’s stock worth $80,678,000 after acquiring an additional 17,376 shares during the period. Invera Wealth Advisors LLC bought a new position in Lam Research during the 4th quarter valued at about $1,906,000. Bill Few Associates Inc. bought a new position in Lam Research during the 4th quarter valued at about $280,000. Simon Quick Advisors LLC bought a new position in Lam Research during the 4th quarter valued at about $240,000. Finally, Kingswood Wealth Advisors LLC increased its position in Lam Research by 77.4% in the 4th quarter. Kingswood Wealth Advisors LLC now owns 715 shares of the semiconductor company’s stock valued at $560,000 after acquiring an additional 312 shares in the last quarter. 84.61% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Timothy Archer sold 10,524 shares of the stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $732.00, for a total transaction of $7,703,568.00. Following the completion of the transaction, the chief executive officer now owns 86,449 shares in the company, valued at $63,280,668. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Ava Hahn sold 2,342 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $732.00, for a total value of $1,714,344.00. Following the transaction, the senior vice president now directly owns 3,433 shares of the company’s stock, valued at $2,512,956. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Timothy Archer sold 10,524 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $732.00, for a total transaction of $7,703,568.00. Following the completion of the transaction, the chief executive officer now directly owns 86,449 shares in the company, valued at $63,280,668. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 19,895 shares of company stock worth $15,666,586. 0.32% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

LRCX has been the subject of several research reports. Morgan Stanley cut shares of Lam Research from an “overweight” rating to an “equal weight” rating and set a $720.00 price objective for the company. in a research report on Friday, December 8th. UBS Group raised their price objective on shares of Lam Research from $885.00 to $1,130.00 and gave the company a “buy” rating in a research report on Tuesday, March 5th. Cantor Fitzgerald reiterated a “neutral” rating and set a $900.00 price target on shares of Lam Research in a research report on Monday, March 4th. Citigroup lifted their price target on shares of Lam Research from $800.00 to $975.00 and gave the stock a “buy” rating in a research report on Thursday, January 25th. Finally, The Goldman Sachs Group lifted their price target on shares of Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a research report on Thursday, January 25th. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $811.68.

Lam Research Stock Performance

Shares of LRCX opened at $965.67 on Thursday. The firm’s 50 day moving average price is $903.24 and its two-hundred day moving average price is $761.16. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.02 and a current ratio of 3.06. The firm has a market cap of $126.60 billion, a P/E ratio of 37.34, a PEG ratio of 3.44 and a beta of 1.51. Lam Research Co. has a twelve month low of $478.77 and a twelve month high of $1,007.39.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 EPS for the quarter, topping the consensus estimate of $7.06 by $0.46. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the prior year, the company posted $10.71 earnings per share. The firm’s revenue was down 28.8% on a year-over-year basis. On average, analysts forecast that Lam Research Co. will post 28.88 EPS for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th will be issued a dividend of $2.00 per share. This represents a $8.00 annualized dividend and a yield of 0.83%. The ex-dividend date is Tuesday, March 12th. Lam Research’s payout ratio is 30.94%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.